Scott W. Woods, MD | Psychiatrist.com

Article

Race and Long-Acting Antipsychotic Prescription at a Community Mental Health Center: A Retrospective Chart Review

April 15, 2012

Neil Krishan Aggarwal, Robert A. Rosenheck, Scott W. Woods, et al

Original Research

Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications: A Prospective Cohort Study

February 9, 2010

Scott W. Woods, Hal Morgenstern, John R. Saksa, et al

Original Research

Effects of Levetiracetam on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study

March 18, 2008

Scott W. Woods, John R. Saksa, C. Bruce Baker, et al

Original Research

Predictors and Time Course of Response Among Panic Disorder Patients Treated With Cognitive-Behavioral Therapy

March 14, 2008

Cindy J. Aaronson, M. Katherine Shear, Raymond R. Goetz, et al

Original Research

Cost-Efficacy of Individual and Combined Treatments for Panic Disorder

July 16, 2007

R. Kathryn McHugh, Michael W. Otto, David H. Barlow, et al

Original Research

Adherence to Conventional and Atypical Antipsychotics After Hospital Discharge

March 1, 2004

Esperanza Diaz, Elizabeth Neuse, Michelle C. Sullivan, et al

Original Research

Chlorpromazine Doses for Antipsychotics

June 15, 2003

Read the full article on Chlorpromazine equivalent doses for the newer atypical antipsychotic medications.

Scott W. Woods

Article

The Economic Burden of Bipolar Disease

November 30, 2000

Scott W. Woods

Letter to the Editor

Cost-Effectiveness of Divalproex Versus Lithium

August 15, 1997

C. Bruce Baker, Scott W. Woods, Michael J. Sernyak

Original Research

Chronic Neuroleptic Exposure in Bipolar Outpatients

May 15, 1997

Michael J. Sernyak, Linda S. Godleski, Ruth A. Griffin, et al